Corporate GovernanceAug 7, 2026, 04:39 PM
Firefly Neuroscience Reduces Authorized Shares to 101M
AI Summary
Firefly Neuroscience, Inc. stockholders approved a significant amendment to its Certificate of Incorporation, decreasing the total authorized shares from 5,001,000,000 to 101,000,000, comprising 100,000,000 common and 1,000,000 preferred shares. Additionally, stockholders approved an amendment to the 2024 Long-Term Incentive Plan, increasing the shares available for grant by 2,000,000 and updating its evergreen provision. Other approvals included the election of Arun Menawat as a director, ratification of CBIZ Canada, LLP as the auditor, and advisory approval of executive compensation.
Key Highlights
- Authorized shares decreased from 5,001,000,000 to 101,000,000.
- Common stock authorized at 100,000,000 shares; preferred stock at 1,000,000 shares.
- Long-Term Incentive Plan shares increased by 2,000,000.
- Arun Menawat elected as Class III director to the Board.
- CBIZ Canada, LLP ratified as independent registered public accounting firm.
- Non-binding advisory approval of named executive officers' compensation.
- All six proposals submitted to stockholders at the Annual Meeting were approved.
Price Impact
More from AIFF